INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Most active filers · 30d

  1. 01Kurtz George0B / 239S · 10 late239 trades$59.22M
  2. 02SPSaba Capital Management, L.P.68B / 23S · 14 late91 trades$30.01M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07CFCheng Chi Fung0B / 42S42 trades$15.33M
  8. 08RJRubinstein Julie0B / 37S37 trades$6.25M
  9. 09SLSpeiser Michael L0B / 35S35 trades$14.00M
  10. 10RARothblatt Martine A0B / 33S33 trades$5.50M

Form 4 transactions

67,558 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
CB
Crowley Kyle BradfordDirector
PUMPProPetro Holding Corp.
Grant or award
A—
11.8K sh
Oct 16, 2026Oct 19, 2026
Page 196 of 1689
← PrevNext →
traded Oct 16, 2026
+3d
SEC Form 4

Evidence

9
WY
Woo Ian YingDirector
NBPNovaBridge Biosciences
Option exercise
M—
13.3K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
RL
Rachlin Evan LockwoodDirector
IAMIambic Therapeutics, Inc.
Derivative conversion
C—
57.8K sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

9
RL
Rachlin Evan LockwoodDirector
IAMIambic Therapeutics, Inc.
Derivative conversion
C—
306.7K sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

9
RL
Rachlin Evan LockwoodDirector
IAMIambic Therapeutics, Inc.
Derivative conversion
C—
1.15M sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

9
VJ
Vogelstein R JacobDirector
IAMIambic Therapeutics, Inc.
Derivative conversion
C—
731.2K sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

9
VJ
Vogelstein R JacobDirector
IAMIambic Therapeutics, Inc.
Derivative conversion
C—
1.14M sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

9
DS
Disbrow Lisa SDirector
CACICACI INTERNATIONAL INC /DE/
Grant or award
A—
418 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
SS
Shani ShaulDirector
RBBNRibbon Communications Inc.
Option exercise
M—
185.2K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
MS
Marmurek Eric SEVP, Chief Financial Officer
RBBNRibbon Communications Inc.
Option exercise
M—
37.5K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
Catalio Capital Management, LP10% Owner
IAMIambic Therapeutics, Inc.
Derivative conversion
C—
2.00M sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

9
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$593K
2,439 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
TS
Thomsen Joel S.TRUSTEE
NONENONESterling Real Estate Trust
Grant or award
A$1,594
66 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
AB
Abbott Swati BargotraDirector
ENSGENSIGN GROUP, INC
Grant or award
A—
600 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
SE
Schreiner Megan E.PRESIDENT
NONENONESterling Real Estate Trust
Grant or award
A$84.69
3 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
GS
Gatoff StevenChief Financial Officer
INSGINSEEGO CORP.
Tax withholding
F$16K
3,872 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
FJ
Flower JohannaDirector
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$255K
1,129 sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

9
SJ
Sarvikas JuhoDirector, Chief Executive Officer
INSGINSEEGO CORP.
Tax withholding
F$15K
3,657 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
PA
Plunkett Debora ADirector
CACICACI INTERNATIONAL INC /DE/
Grant or award
A—
328 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
PM
Polovitz MarkTRUSTEE
NONENONESterling Real Estate Trust
Grant or award
A$923
38 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
CP
Cain James PDirector
AREALEXANDRIA REAL ESTATE EQUITIES, INC.
Grant or award
A—
168 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
VT
Vines TimothyDirector
RFREGIONS FINANCIAL CORP
Grant or award
A$31K
1,144 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
Catalio Capital Management, LP10% Owner
IAMIambic Therapeutics, Inc.
Derivative conversion
C—
742.5K sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

9
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$749K
3,302 sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

9
CB
Campbell BrandiEXECUTIVE VICE PRESIDENT
BMRCBank of Marin Bancorp
Disposition to issuer
D—
18.1K sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

9
Dines DanielDirector, CEO and Chairman, 10% Owner
PATHUiPath, Inc.
Open-market sale · 10b5-1 plan
SELL$658K
47.6K sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

9
ME
Main Jennifer ElizabethDirector
CTEVClaritev Corp
Grant or award
A—
3,113 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
GM
Gordon Susan M.Director
CACICACI INTERNATIONAL INC /DE/
Grant or award
A—
328 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
KM
Kiernan MichaelChief Revenue Officer
NXDRNextdoor Holdings, Inc.
Option exercise
M—
65.0K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
GH
Grayson Bruns HDirector
RBBNRibbon Communications Inc.
Grant or award
A—
19.2K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
TN
Tolia Nirav NDirector, CEO and President, 10% Owner
NXDRNextdoor Holdings, Inc.
Option exercise
M—
110.5K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
DM
Dube Eric MDirector, CHIEF EXECUTIVE OFFICER
TVTXTravere Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$1.79M
200.0K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
VJ
Vogelstein R JacobDirector
IAMIambic Therapeutics, Inc.
Derivative conversion
C—
2.00M sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

9
CE
Carlsen ElyseCAO
RSGREPUBLIC SERVICES, INC.
Grant or award
A$161
1 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
SN
Scruggs Todd N.SVP, CFO
HPHelmerich & Payne, Inc.
Tax withholding
F$18K
481 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
SM
Secora MichaelCFO & Chief Corp Dev Ofcr
IAMIambic Therapeutics, Inc.
Derivative conversion
C—
61.3K sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

9
HP
Hammes Gregory P.TRUSTEE
NONENONESterling Real Estate Trust
Grant or award
A$192
8 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
HP
Hammes Gregory P.TRUSTEE
NONENONESterling Real Estate Trust
Grant or award
A$546
23 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

9
FJ
Flower JohannaDirector
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$338K
1,487 sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC Form 4

Evidence

9
DA
Dianaty AliEVP Ch. Prod. & Tech Officer
MMEDMiniMed Group, Inc.
Grant or award
A—
11.1K sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC Form 4

Evidence

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  5. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  6. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  7. SELLADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
  8. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K